Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 22, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.26. Intellia Therapeutics Inc is up 6.32% from its previous closing price of $28.46. During the last market session, Intellia Therapeutics Inc’s stock traded between $28.43 and $29.84.Intellia Therapeutics Inc stock price live 27.74, this page displays NASDAQ NTLA stock exchange data. View the NTLA premarket stock price ahead of the market session or assess the after hours quote.Intellia Thera CS (NTLA) $27.15 0.59 (2.13%) 16:00 EST NTLA Stock Quote Delayed 30 Minutes.Analyst's Opinion · Consensus Rating. Intellia Therapeutics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to ...2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment …View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Of note is the ratio of INTELLIA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; only 7.7% of US stocks have a lower such ratio. NTLA's price/sales ratio is 51.02; that's higher than the P/S ratio of 96.61% of US stocks.Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 20, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.28. Intellia Therapeutics Inc is up 7.68% from its previous closing price of $28.12. During the last market session, Intellia Therapeutics Inc’s stock traded between $26.18 and $28.17.This stock has a credible chance of climbing, if not soaring. Analysts are almost certainly banking on the occurrence of several catalysts that will be necessary for Intellia to meet their price ...Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 71.50, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +183.06% increase from the …On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.The No. 2 U.S. automaker's lowest-price 2023 model year Mach E version now has a suggested retail price of $39,895, down from $42,995. Other versions including the extended-range premium version ...Today's Open. $27.00. Previous Close. $27.15. Today's High. $27.30. Today's Low. $26.26. The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts.Of note is the ratio of INTELLIA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; only 7.7% of US stocks have a lower such ratio. NTLA's price/sales ratio is 51.02; that's higher than the P/S ratio of 96.61% of US stocks.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Earnings Date. Feb 22, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 75.13. Fair Value is the appropriate price for the shares of a company, based on its... 3 days ago · Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high of $145.00. Intellia Therapeutics. Market Cap. $2B. Today's Change. (-0.99%) -$0.27. Current Price. $26.88. Price as of February 21, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ...Intellia Therapeutics, Inc. Stock price Deutsche Boerse AG Equities 38I US45826J1051 Biotechnology & Medical Research Market Closed - Deutsche Boerse AG. Other stock markets. 10:30:11 2024-01-12 am EST 5-day change ...Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course ...04:03 PM ET 03/02/2023. The Food and Drug Administration cleared Intellia Therapeutics ( NTLA) to begin testing its CRISPR gene-editing technology in people on Thursday, leading NTLA stock to jump ...Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Intellia Therapeutics, Inc. price-consensus-chart | Intellia Therapeutics, Inc. Quote. In fact, over the past month, current quarter estimates have narrowed from a loss of $1.51 per share to a ...1 Jan 2024 ... Key Insights · The projected fair value for Intellia Therapeutics is US$40.78 based on 2 Stage Free Cash Flow to Equity · Current share price of ....Intellia Therapeutics Inc stock price live 27.74, this page displays NASDAQ NTLA stock exchange data. View the NTLA premarket stock price ahead of the market session or assess the after hours quote.Intellia Therapeutics, Inc. price-consensus-chart | Intellia Therapeutics, Inc. Quote. Zacks Rank & Stocks to Consider. Currently, Intellia has a Zacks Rank #3 (Hold).Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics. By Alex Carchidi – Jan 21, 2024 at 8:00AM ... Current Price. $27.18. Price as of February 22, 2024, 4:00 p.m. ET.When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 71.50, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +183.06% increase from the …For instance, Wall Street analysts are currently predicting that shares of the gene editing therapy biotech Intellia Therapeutics (NTLA-2.56%) will rise by 107% to reach a price of more than $87 ...30 Jan 2024 ... Intellia Therapeutics Inc is down 6.07% from its previous closing price of $26.18. During the last market session, Intellia Therapeutics Inc's ...On February 22, Intellia Therapeutics releases earnings for the most recent quarter. Wall Street analysts are expecting losses per share of $1.438. Watch Intellia Therapeutics stock price move in ...Trefis Estimates Intellia Therapeutics Valuation At $26.00 Per Share · Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate · [1] Price To Sales ...About the Intellia Therapeutics, Inc. stock forecast. As of 2024 February 18, Sunday current price of NTLA stock is 27.720$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Intellia Therapeutics stock price has been showing a declining tendency so we believe that similar market …The latest closing stock price for Intellia Therapeutics as of January 05, 2024 is 28.63. The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021. The Intellia Therapeutics 52-week high stock price is 47.48, which is 65.8% above the current share price. The Intellia Therapeutics 52-week low stock price is 22 ...Intellia Therapeutics-stock; ... Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... Gold Price; Oil Price; Silver Price; Copper Price ...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.The Intellia Therapeutics stock prediction for 2025 is currently $ 36.93, assuming that Intellia Therapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 33.12% increase in the NTLA stock price. Intellia Therapeutics Stock Prediction 2030 Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price.On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .5 days ago · The Intellia Therapeutics Inc stock price fell by -0.99% on the last day (Wednesday, 21st Feb 2024) from $27.15 to $26.88. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.88% from a day low at $26.26 to a day high of $27.28. The price has been going up and down for this period, and there has been a 1.17% ... See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ... On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.5 days ago · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 7.53% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...Intellia Therapeutics Inc (0JBU.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics Inc | CINNOBER BOAT: 0JBU ...Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Intellia Therapeutics Stock Forecast. ... The 17 analysts with 12-month price forecasts for NTLA stock have an average target of 76.76, with a low estimate of 40 and a high estimate of 136. The average target predicts an increase of 176.71% from the current stock price of 27.74.Research Intellia Therapeutics' (Nasdaq:NTLA) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...5 days ago ... Wall Street analysts are expecting losses per share of $1.438. Watch Intellia Therapeutics stock price move in real-time ahead here. On ...Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ... When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Intellia Therapeutics stock opened at $26.10 on Friday. The stock’s 50-day moving average is $27.92 and its 200-day moving average is $30.40. The company has a market cap of $2.34 billion, a ...CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some early-stage research.. The cuts come a little over three months after Intellia, one of the first companies founded to turn the gene editing technology into medicines, received a green light from U.S. regulators to begin a late …Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you... Analyst Salveen Richter from Goldman Sachs downgraded the rating on the stock to a Hold and gave it a $32.00 price target. Intellia Therapeutics (NTLA) is a company developing gene editing-based therapies. The timeline for significant events in the company's pipeline stretches into 2024 and beyond.Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intellia Therapeutics wasn’t one of them. The 10 stocks that ...Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen? - Yahoo Finance ... Intellia Therapeutics price target lowered to $24 from $38 at Baird. Baird lowered the firm’s price target on Intellia Therapeutics (NTLA) to $24 from $38 and keeps a Neutral rating on the shares. The firm said they are negative...Earnings Date. Feb 22, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 75.13. Fair Value is the appropriate price for the shares of a company, based on its... 3 days ago · 19 brokerages have issued 1-year price objectives for Intellia Therapeutics' stock. Their NTLA share price targets range from $29.00 to $136.00. On average, they anticipate the company's share price to reach $74.11 in the next year. This suggests a possible upside of 167.2% from the stock's current price. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Intellia Therapeutics, Inc. price-consensus-chart | Intellia Therapeutics, Inc. Quote. Zacks Rank & Stocks to Consider. Currently, Intellia has a Zacks Rank #3 (Hold).May 24, 2002 · Real-time Price Updates for Intellia Thera CS (NTLA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Based on 33 Wall street analysts offering stock ratings for Intellia Therapeutics Inc.(by analysts ranked 0 to 5 stars) Based on 33 analyst. Current; 1M Ago; 3M Ago; Buy. 28. 28. 29. Hold. 5. 5. 5. Sell. 0 0. 0 0. 0 0. Analyst Forecast. ... Intellia Therapeutics Inc.’s price-to-earnings ratio stands at None.View a financial market summary for NTLA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NTLA (Intellia Therapeutics) stock. ... What is Intellia Therapeutics stock price doing today? As of February 23, 2024, NTLA stock price declined to $26.10 with …Feb 7, 2024 · What was the 52-week low for Intellia Therapeutics stock? The low in the last 52 weeks of Intellia Therapeutics stock was 22.67. According to the current price, Intellia Therapeutics is 115.82% ... A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The European Commission bestows orphan drug designation to Intellia's (NTLA) in vivo CRISPR-based investigational therapy, NTLA-2002, for treating hereditary angioedema. Stock rises.Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Intellia Therapeutics, Inc. Appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of ...Get the latest Intellia Therapeutics Inc. (NTLA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 2.9% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...The Intellia Therapeutics Inc (NTLA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $35.09, representing a +29.09% increase from the current price of $27.18. The highest analyst price target is $39.38, and the lowest is $30.80. On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary.Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.28 Oct 2023 ... So (depending on pricing) Intellia may find it tough both to get insurers to cover its medicine, and to find patients willing to pay if they're ...3 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:) and slightly increased the price target to $73 from $72. The adjustment follows Intellia’s fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement. Current Price. $26.10. Price as of February 23, 2024, 4:00 p.m. ET ... Does Intellia Therapeutics have what it takes to make a comeback, or is it too late to get in on the stock? Intellia ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 20, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.28. Intellia Therapeutics Inc is up 7.68% from its previous closing price of $28.12. During the last market session, Intellia Therapeutics Inc’s stock traded between $26.18 and $28.17.Intellia Therapeutics (NTLA) Stock Chart & Stock Price History. $27.74. -0.73 (-2.56%) (As of 02/16/2024 ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability.What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...
Get the latest Intellia Therapeutics, Inc. (NTLA) stock news and headlines to help you in your trading and investing decisions. . Sims 4 toddler cc
Mar 3, 2022 · Intellia Therapeutics. Market Cap. $2B. Today's Change. (-2.13%) -$0.59. Current Price. $27.15. Price as of February 20, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may ... View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN. Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ... Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary.5 days ago ... Wall Street analysts are expecting losses per share of $1.438. Watch Intellia Therapeutics stock price move in real-time ahead here. On ...Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...5 days ago ... Wall Street analysts are expecting losses per share of $1.438. Watch Intellia Therapeutics stock price move in real-time ahead here. On ...Based on 33 Wall street analysts offering stock ratings for Intellia Therapeutics Inc.(by analysts ranked 0 to 5 stars) Based on 33 analyst. Current; 1M Ago; 3M Ago; Buy. 28. 28. 29. Hold. 5. 5. 5. Sell. 0 0. 0 0. 0 0. Analyst Forecast. ... Intellia Therapeutics Inc.’s price-to-earnings ratio stands at None..
Popular Topics
- Ceiling fan installationStrange planet show
- How do you put parental controls on an ipadReservation dispensary near me
- Piggly wiggly food for lessReal food dietitians
- Bruce springsteen concert wrigley fieldFree calendar downloads
- Download video from doodstreamLa vida es fria
- Tamil mp3 songs downloadExamen para licencia de conducir
- Crl stock priceCat penic